Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Obstetrics & Gynecology
- The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen.Nature. 1984; 312: 513-516
- The neu oncogene encodes an epidermal growth factor receptor–related protein.Nature. 1986; 319: 226-230
- Similarity of protein encoded by the c-erbB-2 gene to epidermal growth factor receptor.Nature. 1986; 319: 230-234
- HER-2/neu-targeting gene therapy—a review.Gene. 1995; 159: 65-71
- Tumor promoter and epidermal growth factor stimulate phosphorylation of the c-erbB-2 gene product in MKN-7 human adenocarcinoma cells.Mol Cell Biol. 1988; 8: 1019-1026
- Single-chain antibody-mediated intracellular retention of erbB-2 impairs neu differentiation factor and epidermal growth factor signaling.Mol Cell Biol. 1995; 15: 1182-1191
- Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.Cell. 1986; 45: 649-657
- Studies of HER-2/neu proto-oncogene in human breast and ovarian cancer.Science. 1989; 244: 707-712
- Prognostic value of c-erbB-2 expression in uterine cervical carcinoma.J Clin Pathol. 1992; 45: 594-596
- Immunohistochemical investigation and Northern blot analysis of c-erbB-2 expression in normal, premalignant and malignant tissues of the corpus and cervix uteri.Virchows Arch. 1990; 417: 477-484
- Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix.Cancer. 1994; 73: 148-153
- Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix.Cancer. 1995; 75: 2523-2529
- c-erbB-2 oncoprotein overexpression in uterine cervix carcinoma with glandular differentiation.Am J Clin Pathol. 1995; 104: 634-642
- Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina.Obstet Gynecol. 1990; 76: 381-387
- Human papillomaviruses.Annu Rev Microbiol. 1994; 48: 427-447
Chow LT, Broker TR. Small DNA tumor viruses. In: Nathanson N, editor. Viral pathogenesis. Philadelphia: Lippincott-Raven Press. In press.
- Epidermal growth factor receptor, c-erbB-2 proto-oncogene and estrogen receptor expression in human papillomavirus lesions of the uterine cervix.Int J Gynaecol Obstet. 1994; 13: 234-240
- The biology of human papillomaviruses and their role in cervical carcinogenesis.in: Cytopathology of the female genital tract. Lippincott, Philadelphia1996: 51-72
- In situ hybridization detection of human papillomavirus DNA and messenger RNA in genital condylomas and a cervical carcinoma.Hum Pathol. 1986; 17: 1250-1258
- situ hybridization with RNA probes: an annotated recipe.in: In situ hybridization: applications to neurobiology. Oxford University Press, Oxford (NY)1987: 42-70
- Human papillomavirus type 16 and 18 gene expression in cervical neoplasia.Hum Pathol. 1992; 23: 117-128
- Transforming proteins of the papillomaviruses.Intervirology. 1994; 37: 168-179
- Repressed expression of the HER-2/c-erbB-2 proto-oncogene by the adenovirus Ela gene products.Oncogene. 1991; 6: 343-345
- Negative regulation of the neu promoter by the SV40 large T antigen.Cell Growth Differ. 1993; 4: 1051-1056
- Increased levels and constitutive tyrosine phosphorylation of the epidermal growth factor receptor contribute to autonomous growth of human papillomavirus type 16 immortalized human keratinocytes.Cell Growth Differ. 1994; 5: 537-547
☆From the University of Alabama at Birmingham and the University of Virginia Health Sciences Center.
☆☆Supported in part by National Cancer Institute grant No. CA43629 (M.H.S, L.T.C., and T.R.B.).
★Reprint requests: Phillip Y. Roland, MD, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, OHB Suite 538, 618 S. 20th St., Birmingham, AL 35233-7333.